MetaCap

REGENXBIO (RGNX) Stock Chart

NASDAQ: RGNXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

7.16-0.02 (-0.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RGNX technical summary

RGNX is trading 4.6% below its 50-day simple moving average of $7.51 and 18.5% below its 200-day average of $8.79. The 50-day average is below the 200-day average, a configuration technical analysts associate with a longer-term downtrend. The 14-day Relative Strength Index (RSI) is 44.9, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $5.46 (May 18, 2026) to $16.19 (Jan 22, 2026); the current price sits 16% of the way from the low to the high. Annualized 30-day volatility is 71.6%. Based on the last session's high, low and close, the classic pivot point is $7.11, with first resistance at $7.35 and first support at $6.91.

These indicators describe past price behavior for REGENXBIO; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
16.19 (Jan 22)
1Y low
5.46 (May 18)
Last close
7.16

RGNX price performance

1 week

-6.28%

1 month

-0.14%

3 months

-33.21%

6 months

+12.76%

Year to date

-50.28%

1 year

-39.32%

3 years

-63.28%

5 years

-76.87%

RGNX price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day7.23Price below7.29Price below
10-day7.61Price below7.41Price below
20-day7.43Price below7.45Price below
50-day7.51Price below7.78Price below
100-day9.10Price below8.39Price below
200-day8.79Price below9.18Price below

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)7.79
Resistance 2 (R2)7.55
Resistance 1 (R1)7.35
Pivot point7.11
Support 1 (S1)6.91
Support 2 (S2)6.67
Support 3 (S3)6.47

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis